Article
Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications
12 Jan 2024
Abstract excerpt
The CRISPR/Cas system, identified as a type of bacterial adaptive immune system, have attracted significant attention due to its remarkable ability to precisely detect and eliminate foreign genetic material and nucleic acids. Expanding upon these inherent capabilities, recent investigations have unveiled the potential of reprogrammed CRISPR/Cas 9, 12, and 13 systems for treating viral infections associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
